Orthopedics News: Breaking Orthopedics News, Comments and Articles. - Page: 5

05:21 EDT 1st April 2015 | BioPortfolio

Orthopedics News - Page: 5Twitter RSS

Read the latest Orthopedics News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Orthopedics.

Search or Follow Our Orthopedics - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Orthopedics - Page: 5 News.
You can also follow our Orthopedics - Page: 5 news stories on Twitter: @Orthopedics_Bio

Showing "orthopedics musculoskeletal joints ligaments tendons" News Articles 101 to 125 of 1,400+

Monday 23rd March 2015

Orthopaedic Surgeons On Top of the World, Building a Playground for the Palabra Viva Community

LAS VEGAS, March 24, 2015 /PRNewswire-USNewswire/ -- Last winter, children from Palabra Viva church put crayons to paper and drew pictures of their dream playground. On Tuesday, March 24, those dreams become reality as hundreds of orthopaedic surgeons and other volunteers attending the American Academy of Orthopaedic Surgeons' (AAOS) 2015 Annual Meeting join forces with KaBOOM! and members of the ...

Running barefoot may increase injury risk in older, more experienced athletes

LAS VEGAS, March 24, 2015 /PRNewswire-USNewswire/ -- In recent years there has been an explosion in barefoot running, as well as the purchase and use of "minimalist" running shoes that more closely resemble barefoot running by encouraging the balls of the feet, between the arch and toes, to hit the pavement first. A new study presented today at the 2015 Annual Meeting of the American Academy of Or...

CymaBay Therapeutics Appoints Robert J. Wills, Ph.D. to Board of Directors

NEWARK, CA--(Marketwired - March 24, 2015) - CymaBay Therapeutics, Inc. (NASDAQ: CBAY) today announced the appointment of Robert J. Wills, Ph.D., to the Company's Board of Directors.  "Rob brings to CymaBay over 35 years of pharmaceutical experience, including preclinical and clinical research and development, business development and strategic partnering," said Harold Van Wart, President and ...

Foundation Radiology Group Names Richard Vance as CEO

PITTSBURGH, PA -- (Marketwired) -- 03/24/15 -- Foundation Radiology Group, one of the nation's largest providers of radiology services to hospitals, has capped a year of growth in 2014 by appointing Dr. Richard Vance as Chief Executive Officer and board member. A successful healthcare services executive, Dr. Vance has over 30 years of experience in healthcare services and IT, product development,...

Early imaging for back pain in older adults 'does not lead to better outcomes'

A new study has shown that early imaging for back pain in older adults is generally not associated with better outcomes.Carried out by the University of Washington and published in the Journal of the American Medical Association, the study compared function and pain after 12 months among older adults with back pain who received imaging interventions within six weeks to those who did not.Currently,...

CORRECTING and REPLACING DJO Surgical Launches the Exprt, a Revolutionary Revision Knee Using 75% Fewer Instruments at a Dramatically Lower Cost

In the seventh paragraph, Dr. Richard Iorio is "a New York City-based joint replacement specialist." (Instead of the "Chief of Adult Reconstructive Surgery at NYU Langone Medical Center.") The corrected release reads: DJO SURGICAL LAUNCHES THE EXPRT, A REVOLUTIONARY REVISION KNEE USING 75% FEWER INSTRUMENTS AT A DRAMATICALLY LOWER COST ...

Blood test could provide an early arthritis warning

"Arthritis breakthrough as new test diagnoses condition up to a decade earlier," the Mail Online reports. The test measures proteins linked with arthritis.The study aimed to see whether a blood test could be developed that could distinguish between different types of early stage arthritis.The study included groups of people with established diagnoses, including those diagnosed with early...

TraumaCad Orthopedic Pre-operative Planning and Templating Solution Receives FDA Clearance on New Mobile Version

Mobile Digital templating technology allows better accessibility to pre-operative planning for total hip replacement Voyant Health, a Brainlab Company, announced today that it has received FDA clearance on

DJO Surgical Launches the Exprt, a Revolutionary Revision Knee Using 75% Fewer Instruments at a Dramatically Lower Cost

DJO Global, Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, is launching the new Exprt™ Precision System for highly proficient revision knee surgeons at this year’s Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS booth #4425) in Las Vegas, NV. In addition, surgeon...

Flower Orthopedics Completes $4.5 Million Series C Equity Financing

HORSHAM, Pa., March 23, 2015 /PRNewswire/ -- Flower Orthopedics Corporation (Flower Orthopedics) today announced that it has successfully completed a $4.5 million Series C equity raise. Proceeds from the financing will be used for working capital and to fund the company's growth strategies. Flower Orthopedics is the creator of the FlowerCube™, a standardized, single-use bone fixation concept...

NovaBone Products Receives 501(k) Clearance for Wound Dressing

NovaBone Products, a leading biologics bone graft device company, has announced 501(k) clearance from the US Food and Drug Administration for collagen wound dressings. NovaPlug wound dressing. (Photo: Business Wire) The products receiving clearance and now available for the dental industry are NovaTape™ and NovaP

ISA Scientific, Yissum, Hadasit and the Kennedy Trust for Rheumatology Research to Collaborate on Treating Diabetes and Other Serious Health Conditions with Cannabidiol

Yissum Research Development Company Ltd. (Yissum), the technology transfer company of the Hebrew University of Jerusalem, Hadasit Ltd. (Hadasit), the technology transfer company of the Hadassah Medical Organization in Jerusalem, and the Kennedy Trust for Rheumatology Research (KIR) in the United Kingdom announced today that they have signed an exclusive wo...

Federally Funded Project Establishes First National Database of Comprehensive Benchmarks for Total Hip and Knee Joint Replacement

Offers New Insight into Appropriateness Criteria and Timing of Surgery A 4-year, $12 million national research project funded by the Agency for Healthcare Research and Quality (AHRQ) has surpassed its original goal, culminating in the establishment of the most comprehensive U.S. database on total hip and knee joint replacement patients and their surgical ...

Long-term effect of deep brain stimulation on pain in patients with Parkinson's disease

Patients with Parkinson disease who experienced pain before undergoing subthalamic nucleus deep brain stimulation (STN DBS) had that pain improved or eliminated at eight years after surgery, although the majority of patients developed new pain, mostl...

OrthoSensor Adds $19 Million through Series C Preferred Stock Financing

DANIA BEACH, Fla., March 23, 2015 /PRNewswire/ -- OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE™, OrthoSensor's leading pro...

Orthopedic Software Market Worth $308.5 Million by 2020

DALLAS, March 23, 2015 /PRNewswire/ -- According to a new market research report "Orthopedic Software Market by Product (Pre-operative Planning, Orthopedic EHR, Orthopedic PACS) by Applications (Orthopedic Surgery, Joint Replacement, Fracture Management, Pediatric Assessment) by Mode of Delivery - Global Forecast to 2020", published by MarketsandMarkets, the Orthopedic Software Market is exp...

Cipher Pharmaceuticals acquires Canadian rights to novel treatment for psoriasis and rheumatoid arthritis

MISSISSAUGA, ON, March 23, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced it has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Can-Fite Biopharma ("Can-Fite") (NYSE MKT: CANF) (TASE: CFBI) for moderate to severe plaque psoriasis and rheumatoid arthritis. CF101 recently completed a...

Nevada Pain Now Offering Stem Cell Therapy to Help Patients Delay or Avoid Joint Replacement

Nevada Pain, the top pain management clinics in Las Vegas and Henderson areas, are now offering stem cell therapy to help patients delay or avoid the need for joint replacement. The treatments are cutting edge, outpatient, and highly effective. Las Vegas, Nevada (PRWEB) March 23, 2015 Nevada Pain, the top pain management clinics in Las Vegas and Henderson areas, are now offering stem cell therapy...

Global Osteoarthritis Market 2015-2019

About OA OA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, ...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014

Recently added to the BioPortfolio report store, Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014 is a new report from GlobalData published on 2015-02-14. This 142-page report is available in PDF from $1500. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014 Summary GlobalData's “Partnerships, Licensing, Inve...

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Recently added to the BioPortfolio report store, Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth is a new report from Technavio published on 2014-12-30. This 139-page report is available in PDF from $4995. Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improv...

Stryker Settlement News: Legal-Bay Lawsuit Settlement Funding Reports Extended Enrollment Deadline for Stryker Orthopedics Rejuvenate Hip System Settlement

ATLANTA, March 23, 2015 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that the enrollment deadline for the Stryker Orthopedics Rejuvenate Hip System settlement has been extended to March 30th, 2015. The initial deadline to enroll in the settlement was early March of this year, but the deadline has been extended to give more patients who have been affect...

Sunday 22nd March 2015

CymaBay Therapeutics to Host Key Opinion Leader Meeting on March 27 in New York City

NEWARK, CA--(Marketwired - March 23, 2015) - CymaBay Therapeutics, Inc. (NASDAQ: CBAY) today announced that it will host a Key Opinion Leader breakfast focused on gout, current treatment options and the company's Phase 2 drug candidate arhalofenate. The event and live webcast will take place on Friday, March 27 from 8:00 am-9:30 am Eastern Time in New York City. The meeting will feature a keynot...

OSU Surgeons Announce New Achilles Repair Technique

COLUMBUS, OH -- The Ohio State University Wexner Medical Center announced March 5 the development of a new surgical technique, published online by Techniques in Orthopaedics, to repair torn Achilles tendons. "We're constantly looking for new and better ways to do surgery, make it safer, make it faster, make it more efficient, and minimize the risk of complications," said Timothy Miller, assista...

Friday 20th March 2015

Rheumatoid arthritis pain: Tips for protecting your joints


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks